Company intelligence / Profile preview

Octalfa

Lyon, France

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Octalfa is not a clinical-stage company itself but rather a venture capital and holding company that invests in and co-funds biotech and pharmaceutical companies. Its portfolio companies are at various developmental stages.

Therapeutic areas: OncologyRare Diseases
Modalities: AntibodyPeptideSmall molecule
Industry: Investors

Partnerships

Academic partnerships through portfolio companiesMontpellier Cancer Research Institute (Ventuno Biotech)

Beyond the preview

Go deeper on Octalfa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Octalfa.

Explore the full profile